• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用扩散加权质子磁共振波谱对细胞内癌细胞代谢及对氯硝胺治疗的反应进行无创实时监测。

Noninvasive real-time monitoring of intracellular cancer cell metabolism and response to lonidamine treatment using diffusion weighted proton magnetic resonance spectroscopy.

作者信息

Mardor Y, Kaplan O, Sterin M, Ruiz-Cabello J, Ash E, Roth Y, Ringel I, Cohen J S

机构信息

Advanced Technology Center, Sheba Medical Center, Tel Hashomer, Israel.

出版信息

Cancer Res. 2000 Sep 15;60(18):5179-86.

PMID:11016646
Abstract

We have used diffusion-weighted proton magnetic resonance spectroscopy (DWMRS) to noninvasively selectively observe only the intracellular metabolites of breast cancer and melanoma cell lines in vitro in real time. Breast cancer cell lines representing different stages in breast cancer progression were chosen for study. Intracellular biochemical profiles of six cell lines perfused in alginate beads were obtained. Spectral differences between groups of cell lines, including choline, lactate, and threonine peaks, were investigated. We also monitored response to the antineoplastic agent, lonidamine (LND), as a function of time and drug concentration in perfused cancer cells. Previous studies reported that this drug induced intracellular acidification and lactate accumulation. Diffusion weighted proton spectra demonstrated a 2- to 9-fold increase in the intracellular lactate signal as a response to LND treatment in several cancer cell lines. These results are consistent with the hypothesis that the principal mechanism of LND in some cancer cells is marked inhibition of lactate transport. Moreover, we have shown that there is a factor of two to three between the response of melanoma cells and that of some types of breast cancer cells. The higher sensitivity of the melanoma cells, as predicted by proton DWMRS, was correlated with changes in water-suppressed magnetic resonance spectra and confirmed by a biological assay. This study demonstrates the feasibility of using DWMRS for monitoring intracellular metabolism and for studying the effects and mechanisms of action of anticancer drugs. We believe that this method can be used for noninvasive clinical applications, such as the differentiation between benign and malignant tissue, real-time monitoring of response to therapy, dose response, and toxicity effects.

摘要

我们已使用扩散加权质子磁共振波谱法(DWMRS)在体外实时非侵入性地选择性观察乳腺癌和黑色素瘤细胞系的细胞内代谢物。选择代表乳腺癌进展不同阶段的乳腺癌细胞系进行研究。获得了在藻酸盐珠中灌注的六种细胞系的细胞内生化图谱。研究了细胞系组之间的光谱差异,包括胆碱、乳酸和苏氨酸峰。我们还监测了灌注癌细胞中抗肿瘤药物氯尼达明(LND)的反应随时间和药物浓度的变化。先前的研究报道,这种药物会诱导细胞内酸化和乳酸积累。扩散加权质子谱显示,在几种癌细胞系中,作为对LND治疗的反应,细胞内乳酸信号增加了2至9倍。这些结果与以下假设一致,即LND在某些癌细胞中的主要机制是显著抑制乳酸转运。此外,我们已经表明,黑色素瘤细胞与某些类型的乳腺癌细胞的反应之间存在两到三倍的差异。如质子DWMRS所预测的,黑色素瘤细胞的更高敏感性与水抑制磁共振谱的变化相关,并通过生物学测定得到证实。这项研究证明了使用DWMRS监测细胞内代谢以及研究抗癌药物的作用效果和作用机制的可行性。我们相信,这种方法可用于非侵入性临床应用,如良性和恶性组织的鉴别、治疗反应的实时监测、剂量反应和毒性作用。

相似文献

1
Noninvasive real-time monitoring of intracellular cancer cell metabolism and response to lonidamine treatment using diffusion weighted proton magnetic resonance spectroscopy.使用扩散加权质子磁共振波谱对细胞内癌细胞代谢及对氯硝胺治疗的反应进行无创实时监测。
Cancer Res. 2000 Sep 15;60(18):5179-86.
2
Mechanism of action of the antineoplastic drug lonidamine: 31P and 13C nuclear magnetic resonance studies.抗肿瘤药物氯尼达明的作用机制:31P和13C核磁共振研究
Cancer Res. 1995 Jul 1;55(13):2814-21.
3
Levels of phospholipid metabolites in breast cancer cells treated with antimitotic drugs: a 31P-magnetic resonance spectroscopy study.抗有丝分裂药物处理的乳腺癌细胞中磷脂代谢物水平:一项31P磁共振波谱研究。
Cancer Res. 2001 Oct 15;61(20):7536-43.
4
Comparison of action of the anti-neoplastic drug lonidamine on drug-sensitive and drug-resistant human breast cancer cells: 31P and 13C nuclear magnetic resonance studies.抗肿瘤药物氯尼达明对人乳腺癌敏感细胞和耐药细胞作用的比较:31P和13C核磁共振研究
Breast Cancer Res Treat. 1997 Mar;43(1):15-25. doi: 10.1023/a:1005781320906.
5
Water diffusion in the different microenvironments of breast cancer.乳腺癌不同微环境中的水扩散
NMR Biomed. 2004 Jun;17(4):170-80. doi: 10.1002/nbm.882.
6
Glucose metabolism in drug-sensitive and drug-resistant human breast cancer cells monitored by magnetic resonance spectroscopy.通过磁共振波谱监测药物敏感和耐药人乳腺癌细胞中的葡萄糖代谢。
Cancer Res. 1988 Feb 15;48(4):870-7.
7
Melanoma tumors acquire a new phospholipid metabolism phenotype under cystemustine as revealed by high-resolution magic angle spinning proton nuclear magnetic resonance spectroscopy of intact tumor samples.通过对完整肿瘤样本进行高分辨率魔角旋转质子核磁共振光谱分析发现,黑色素瘤肿瘤在西司他丁作用下获得了一种新的磷脂代谢表型。
Cancer Res. 2002 Mar 15;62(6):1890-7.
8
Monitoring the therapeutic response of locally advanced breast cancer patients: sequential in vivo proton MR spectroscopy study.监测局部晚期乳腺癌患者的治疗反应:序贯体内质子磁共振波谱研究
J Magn Reson Imaging. 2006 Aug;24(2):325-32. doi: 10.1002/jmri.20646.
9
Role of nuclear magnetic resonance spectroscopy (MRS) in cancer diagnosis and treatment: 31P, 23Na, and 1H MRS studies of three models of pancreatic cancer.核磁共振波谱法(MRS)在癌症诊断与治疗中的作用:三种胰腺癌模型的31P、23Na和1H MRS研究
Cancer Res. 1997 Apr 15;57(8):1452-9.
10
Noninvasive magnetic resonance spectroscopic pharmacodynamic markers of the choline kinase inhibitor MN58b in human carcinoma models.胆碱激酶抑制剂MN58b在人类癌症模型中的无创磁共振波谱药效学标志物
Cancer Res. 2006 Jan 1;66(1):427-34. doi: 10.1158/0008-5472.CAN-05-1338.

引用本文的文献

1
An Update on MR Spectroscopy in Cancer Management: Advances in Instrumentation, Acquisition, and Analysis.癌症管理中磁共振波谱的最新进展:仪器、采集和分析的进展。
Radiol Imaging Cancer. 2024 May;6(3):e230101. doi: 10.1148/rycan.230101.
2
Determination of Intra- and Extracellular Metabolic Adaptations of 3D Cell Cultures upon Challenges in Real-Time by NMR.通过实时 NMR 技术测定 3D 细胞培养物在受到挑战时的细胞内外代谢适应性
Int J Mol Sci. 2022 Jun 12;23(12):6555. doi: 10.3390/ijms23126555.
3
Live monitoring of cellular metabolism and mitochondrial respiration in 3D cell culture system using NMR spectroscopy.
使用核磁共振波谱法对三维细胞培养系统中的细胞代谢和线粒体呼吸进行实时监测。
Analyst. 2021 Jul 7;146(13):4326-4339. doi: 10.1039/d1an00041a. Epub 2021 Jun 9.
4
The Potential of Lonidamine in Combination with Chemotherapy and Physical Therapy in Cancer Treatment.氯尼达明联合化疗和物理治疗在癌症治疗中的潜力
Cancers (Basel). 2020 Nov 11;12(11):3332. doi: 10.3390/cancers12113332.
5
Effect of Lonidamine on Systemic Therapy of DB-1 Human Melanoma Xenografts with Temozolomide.氯尼达明对替莫唑胺全身治疗DB-1人黑色素瘤异种移植瘤的影响。
Anticancer Res. 2017 Jul;37(7):3413-3421. doi: 10.21873/anticanres.11708.
6
Topiramate induces acute intracellular acidification in glioblastoma.托吡酯可诱导胶质母细胞瘤发生急性细胞内酸化。
J Neurooncol. 2016 Dec;130(3):465-472. doi: 10.1007/s11060-016-2258-y. Epub 2016 Sep 9.
7
Mechanism of antineoplastic activity of lonidamine.氯尼达明的抗肿瘤活性机制。
Biochim Biophys Acta. 2016 Dec;1866(2):151-162. doi: 10.1016/j.bbcan.2016.08.001. Epub 2016 Aug 4.
8
Comparison of the Lonidamine Potentiated Effect of Nitrogen Mustard Alkylating Agents on the Systemic Treatment of DB-1 Human Melanoma Xenografts in Mice.氯尼达明增强氮芥类烷化剂对小鼠体内DB-1人黑色素瘤异种移植瘤全身治疗效果的比较。
PLoS One. 2016 Jun 10;11(6):e0157125. doi: 10.1371/journal.pone.0157125. eCollection 2016.
9
The anti-tumour agent lonidamine is a potent inhibitor of the mitochondrial pyruvate carrier and plasma membrane monocarboxylate transporters.抗肿瘤药物氯尼达明是线粒体丙酮酸载体和质膜单羧酸转运体的强效抑制剂。
Biochem J. 2016 Apr 1;473(7):929-36. doi: 10.1042/BJ20151120. Epub 2016 Feb 1.
10
Effects of hyperglycemia on lonidamine-induced acidification and de-energization of human melanoma xenografts and sensitization to melphalan.高血糖对氯尼达明诱导的人黑色素瘤异种移植瘤酸化、能量耗竭及对美法仑敏感性的影响。
NMR Biomed. 2015 Mar;28(3):395-403. doi: 10.1002/nbm.3260.